📰 ET Markets 🔴 BEARISH 🕒 30 Oct 2026, 10:14 PM IST

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

📊

Market & Financial Impact: Sun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Revenue grew 11.8%, supported by strong domestic and emerging market sales, while US formulations weakened.

💡

Actionable Insight: 🔴 Bearish Risk: Regulatory scrutiny, profit decline, or sell-off risk may create near-term volatility.

Sun Pharma reports lower quarterly profit despite revenue growth, as exceptional costs weigh on earnings while India and emerging markets drive business expansion.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Can new data protection law guard against SBI-like data breaches?

KYB and KYC: Quick commerce, the Damani premium and what DMart must deliver – 3rd and concluding part

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

🔥 More Live Market Stories

American workers are finding their take-home pay isn’t keeping up with inflation, with their wallets ‘stretching thinner and thinner’

[BSHSL] Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Bombay Super Hybrid Seeds Limited

Binance's $6.3bn crypto hack biggest in history

Sagility promoter sells 12% stake for Rs 2,395 crore; Smallcap World Fund raises holding in Lotus Developers

[DELHIVERY] Analysts/Institutional Investor Meet/Con. Call Updates - Delhivery Limited

[DIVGIITTS] Resignation - Divgi Torqtransfer Systems Limited